Gilead Sciences

GILD | NASDAQ | 40 Followers
$124.70 -0.77% -$0.97
Follow
Overview Metrics Financials

Feed

Read More

Gilead Sciences: renewed growth story after years of stagnation

Company shares Gilead Sciences $GILD have risen by 44 %indicating a significant turnaround after years of stagnation. This growth trend is supported by new opportunities in innovative drugs and potential entry into the obesity market.

Key growth drivers for $GILD

1. Innovative medicines

- Lenacapavir: A promising HIV...
Read more
2
Share
Zobrazit další komentáře

Interesting company, however I was probably most intrigued by $NVO.
Like 0
Don't have an account? Join us

Log in to Bulios

Continue with Google Continue with Apple Continue with Facebook
Or use email and password
Reset password
Already a member? Log in

Create Bulios profile

Continue with
Or use email and password
You can use lowercase letters, numbers, and underscores

Why Bulios?

One of the fastest growing investor communities in Europe

Comprehensive data on thousands of stocks from around the world

Current information from global markets and individual companies

Education and exchange of investment experience among investors

Fair prices, portfolio tracker, stock screener and other tools
Menu StockBot
Tracker
Upgrade